V804M RET mutation and familial medullary thyroid carcinoma: Report of a large family with expression of the disease only in the homozygous gene carriers
- 1 May 2002
- Vol. 131 (5) , 509-514
- https://doi.org/10.1067/msy.2002.123006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?Cancer, 2000
- Novel point mutation in exon 10 of theRET proto-oncogene in a family with medullary thyroid carcinomaAmerican Journal of Medical Genetics, 1998
- A New Hot Spot for Mutations in the ret Protooncogene Causing Familial Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2AJournal of Clinical Endocrinology & Metabolism, 1998
- A Novel Point Mutation in the Intracellular Domain of the ret Protooncogene in a Family with Medullary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1997
- Mutation of RET codon 768 is associated with the FMTC phenotypeClinical Genetics, 1997
- The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2JAMA, 1996
- RET receptor tyrosine kinase gene mutations: molecular biological, physiological and clinical aspectsEuropean Journal of Clinical Investigation, 1996
- Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation ConsortiumJournal of Internal Medicine, 1995
- Analysis ofRET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomasCancer, 1995
- Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTCNature Genetics, 1994